Page last updated: 2024-08-24

tenocyclidine and mdl 105519

tenocyclidine has been researched along with mdl 105519 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baron, BM; Fadayel, GM; Harrison, BL; Kehne, JH; McCloskey, TC; Murawsky, MK; Nyce, P; Salituro, FG; Schmidt, CJ; Senyah, Y; Siegel, BW; Taylor, VL; van Giersbergen, PL; White, HS1

Other Studies

1 other study(ies) available for tenocyclidine and mdl 105519

ArticleYear
Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist.
    European journal of pharmacology, 1997, Apr-04, Volume: 323, Issue:2-3

    Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Calcium Channels; Cells, Cultured; Cerebellum; Cyclic GMP; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Indoles; Ligands; Male; Mice; Mice, Inbred DBA; Motor Activity; N-Methylaspartate; Phencyclidine; Rats; Rats, Inbred F344; Rats, Wistar; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Sodium Channels

1997